Deepak Chadha

Deepak Chadha

Plus aucun poste en cours

Fortune : 19 692 $ au 31/03/2024

54 ans
Health Technology
Consumer Services
Electronic Technology

Profil

Deepak Chadha worked as Vice President-Regulatory Affairs at Allergan, Inc. from 2007 to 2014.
Prior to that, he held the position of Vice President-Global Regulatory Affairs at Inamed Corp.
from 2004 to 2007.
He also served as Chief Research & Development Officer at Vical, Inc., Vice President-Regulatory Affairs at Kythera Biopharmaceuticals LLC, Principal at Stryker Biotech, Spine, Osteosynthesis & Development, and Principal at Biomeasure, Inc. From 2014 to 2016, he was Vice President-Regulatory Affairs at Suneva Medical, Inc. Currently, he is the Chief Operating, Research & Development Officer at Fresh Tracks Therapeutics, Inc. since 2016.
Mr. Chadha holds an MBA from California State University-Dominguez Hills.
He also has a graduate degree from Jamia Hamdard University and an undergraduate degree from Berhampur University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/09/2023 21 759 ( 0,36% ) 19 692 $ 31/03/2024

Anciens postes connus de Deepak Chadha

SociétésPosteFin
FRESH TRACKS THERAPEUTICS, INC. Chief Operating Officer 01/09/2023
General Counsel 01/01/2016
ALLERGAN, INC. General Counsel 01/01/2014
Corporate Officer/Principal 01/01/2007
Chief Tech/Sci/R&D Officer -
Voir l'expérience en détail de Deepak Chadha

Formation de Deepak Chadha

California State University-Dominguez Hills Masters Business Admin
Berhampur University Undergraduate Degree
Jamia Hamdard University Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Deepak Chadha

Relations

79

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées8

Health Technology

Health Technology

Health Technology

Health Technology

Stryker Biotech, Spine, Osteosynthesis & Development

Health Technology

Electronic Technology

Fresh Tracks Therapeutics, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Deepak Chadha